BP (BP) Stock Declines While Market Improves: Some Information for Investors

BP (BP) recently declined 1.74% to $33.86, significantly underperforming the broader market and its Oils-Energy sector over the past month. The company is slated to report Q3 2025 earnings on November 4, 2025, with projections indicating a 15.66% year-over-year EPS decline to $0.70, despite an anticipated 30.42% revenue increase to $63.03 billion. While the Zacks Consensus EPS estimate saw a 2.24% upward revision recently, BP holds a 'Hold' rating (Zacks Rank #3) and trades at a forward P/E of 12.83 and PEG ratio of 2.04, both representing a premium to its industry averages, despite its industry being in the top 36% overall.

Analysis

BP's recent stock performance indicates significant relative weakness, with a 1.74% decline to $33.86 during a session where major indices gained, and a flat 0% return over the past month, lagging both its sector's 0.54% gain and the S&P 500's 3.94% rise. The forward-looking consensus estimates present a conflicting scenario for its upcoming earnings release. While revenues are projected to grow substantially by 30.42% year-over-year to $63.03 billion for the quarter, earnings per share are expected to decline by 15.66% to $0.70. This trend of top-line growth failing to translate to the bottom line is also reflected in full-year estimates, which call for a 13.63% revenue increase but a 17.48% drop in EPS. Despite this negative earnings trajectory, the Zacks Consensus EPS estimate has seen a modest 2.24% upward revision in the last month, contributing to its neutral #3 (Hold) rank. Valuation appears stretched, as BP's forward P/E of 12.83 and PEG ratio of 2.04 both trade at a premium to their respective industry averages of 10.65 and 1.97, suggesting the market may not be fully pricing in the anticipated profit contraction.

Key Decisions for Investors

• Investors should scrutinize the upcoming earnings report for management's commentary on margin pressures, as the divergence between strong revenue growth and declining EPS is a primary concern.
• Given the stock's premium valuation relative to its industry peers and its recent market underperformance, a cautious stance is warranted until there is clarity on a path back to earnings growth.
• Monitor for further analyst estimate revisions, as the recent slight upward tick in EPS estimates could be an early, albeit minor, signal of stabilizing fundamentals or a potential earnings surprise.